BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16897188)

  • 1. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.
    Chim CS; Fung TK; Wong KF; Lau JS; Liang R
    J Hum Genet; 2006; 51(9):832-838. PubMed ID: 16897188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
    Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
    J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.
    Chim CS; Chan WW; Kwong YL
    J Clin Pathol; 2008 Jul; 61(7):844-7. PubMed ID: 18587015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
    Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
    Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
    Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
    Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients.
    Chim CS; Fung TK; Wong KF; Lau JS; Law M; Liang R
    J Clin Pathol; 2006 Sep; 59(9):921-6. PubMed ID: 16565223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.
    Katzenellenbogen RA; Baylin SB; Herman JG
    Blood; 1999 Jun; 93(12):4347-53. PubMed ID: 10361133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
    Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S
    World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of p53 tumor suppressor pathway genes in chronic lymphocytic leukemia.
    Isin M; Yenerel M; Aktan M; Buyru N; Dalay N
    DNA Cell Biol; 2012 May; 31(5):777-82. PubMed ID: 22047081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.
    Gutierrez MI; Siraj AK; Bhargava M; Ozbek U; Banavali S; Chaudhary MA; El Solh H; Bhatia K
    Leukemia; 2003 Sep; 17(9):1845-50. PubMed ID: 12970785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation.
    Sturm I; Bosanquet AG; Radetzki S; Hummel M; Dörken B; Daniel PT
    Int J Cancer; 2006 May; 118(9):2329-36. PubMed ID: 16331630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
    Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
    Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
    Tang X; Khuri FR; Lee JJ; Kemp BL; Liu D; Hong WK; Mao L
    J Natl Cancer Inst; 2000 Sep; 92(18):1511-6. PubMed ID: 10995806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation.
    Krassenstein R; Sauter E; Dulaimi E; Battagli C; Ehya H; Klein-Szanto A; Cairns P
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):28-32. PubMed ID: 14734448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
    Christoph F; Hinz S; Kempkensteffen C; Weikert S; Krause H; Schostak M; Schrader M; Miller K
    J Cancer Res Clin Oncol; 2007 Jun; 133(6):343-9. PubMed ID: 17160380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.